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Abstract
Setting: Under India’s Revised National Tuberculosis Control Programme (RNTCP), .15% of previously-treated patients in
the reported 2006 patient cohort defaulted from anti-tuberculosis treatment.
Objective: To assess the timing, characteristics, and risk factors for default amongst re-treatment TB patients.
Methodology: For this case-control study, in 90 randomly-selected programme units treatment records were abstracted
from all 2006 defaulters from the RNTCP re-treatment regimen (cases), with one consecutively-selected non-defaulter per
case. Patients who interrupted anti-tuberculosis treatment for .2 months were classified as defaulters.
Results: 1,141 defaulters and 1,189 non-defaulters were included. The median duration of treatment prior to default was 81
days (25%–75% interquartile range 44–117 days) and documented retrieval efforts after treatment interruption were
inadequate. Defaulters were more likely to have been male (adjusted odds ratio [aOR] 1.4, 95% confidence interval [CI] 1.2–
1.7), have previously defaulted anti-tuberculosis treatment (aOR 1.3 95%CI 1.1–1.6], have previous treatment from non-
RNTCP providers (AOR 1.3, 95%CI 1.0–1.6], or have public health facility-based treatment observation (aOR 1.3, 95%CI 1.1–
1.6).
Conclusions: Amongst the large number of re-treatment patients in India, default occurs early and often. Improved pre-
treatment counseling and community-based treatment provision may reduce default rates. Efforts to retrieve treatment
interrupters prior to default require strengthening.
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Introduction
India accounts for nearly 20% of the global incidence of TB,
with an estimated annual incidence of 1.9 million tuberculosis (TB)
cases [1]. Under the Revised National TB Control Programme
(RNTCP), treatment outcomes for new patients, have met or
exceeded international targets; over 85% of the 553,660 new
smear-positive patients notified in 2006 were successfully treated
[2].
The treatment outcome ‘‘default’’ under RNTCP is a patient
who has not taken anti-TB drugs for 2 months or more
consecutively after starting treatment [3]. The public health and
clinical consequences of TB treatment default are severe. Relative
to those who complete treatment, patients who default may
perpetuate TB transmission and have high post-treatment
mortality and rates of recurrent disease [4,5]. Among new
patients, the proportion of patients who defaulted from RNTCP
has been relatively low (,8%). Risk factors for default among new
patients have been reported in several studies from India [6,7,8,9].
In India, nearly one-quarter of TB patients are notified as ‘‘re-
treatment’’—i.e. with at least one-month history of previous anti-
TB treatment [2]. This group is extremely diverse, with patients
having been treated with varying durations and anti-TB regimens.
These patients may have been treated many years prior or may
have only recently failed or defaulted, and may have been treated
by the private or public sectors (or both) in the past [10].
Compared to new patients, re-treatment TB patients have much
worse treatment outcomes, due to high rates of default. In 2006,
among 259,059 notified re-treatment cases, 39,699 (15.3%) were
reported to have defaulted [2] when compared to default rates of
7% among new cases. No information has been reported about the
profile of these re-treatment defaulters, timing of default, or the
extent of programme efforts to retrieve defaulters. Furthermore,
risk factors for default may differ from new patients.
We conducted a case-control study to understand the basic clinical
and demographic characteristics of patients who defaulted from
RNTCP re-treatment regimens, assess the patterns and timing of
treatment interruptions, and evaluate risk factors for default.
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Treatment of TB in India [3]
In India, patients are evaluated for TB using a standard
diagnostic algorithm, starting with sputum-smear microscopy
examinations for persons suspected of TB. Patients who are
smear-positive are immediately initiated on treatment, and those
who are smear-negative are evaluated further with antibiotic trial,
repeat sputum examination, radiograph, and clinical evaluation.
All patients diagnosed with TB are evaluated for history of
previous anti-TB treatment and those with $1 month of treatment
from any source are classified as re-treatment cases and prescribed
the WHO-recommended Category II treatment, directly-observed
and dosed thrice-weekly. RNTCP uses a 3-month (36 doses)
intensive phase (IP) of isoniazid, pyrazinamide, rifampicin, and
ethambutol (with streptomycin for the first 24 doses), and a 5-
month (66 doses) continuation phase (CP) of isoniazid, rifampicin,
and ethambutol. If a patient remains smear-positive after IP, then
the same is extended by 1 month. Treatment duration is
determined by the number of doses taken; missed doses lead to
a longer total duration of treatment.
A standard TB treatment card is maintained for every TB
patient at the nearest health unit. The card records necessary
contact, demographic, clinical, and treatment information, and
completed by the treating medical officer.
Adherence to RNTCP treatment is ensured for all TB patients
by the use of directly-observed treatment (DOT), wherein an
observer watches and supports the patient in taking their drugs. All
patients are given a choice to choose their DOT provider who
may be either a health worker in the public sector health-care
facility or a community volunteer. Community volunteers may
include local teachers, private providers, practitioners of tradi-
tional medicine, or anyone other than a family member. In the
case of re-treatment patients, the need to provide injectable drug
during the first 2 months of treatment limits the choice of DOT
provider to those practitioners who are legally allowed to
administer injectable drugs, i.e. public sector health-care workers,
non-public sector health-care workers, or registered medical
practitioners.
The RNTCP has well defined guidelines on how to retrieve TB
patients who interrupt treatment [11]. Retrieval actions are by
home visits and or by phone calls if that information is recorded on
the treatment cards. The first retrieval action is to be conducted by
the DOT provider, within 24 hours of a missed dose. If that is
unsuccessful then it is reported to the next level of supervisors (i.e.,
multi-purpose paramedical health workers, medical officers), and
the local medical officer is responsible for organizing retrieval of
the patient within 1 week, followed by the TB programme staff
(senior treatment supervisor or TB health visitor) within 2 weeks.
Retrieval actions are required to be documented on a dedicated
section of the individual patient treatment card.
Design and Sampling
For this retrospective case-control study, cluster sampling was
used to generate a nationally representative sample while retaining
operational feasibility of data collection; clusters were the basic TB
programme management unit (tuberculosis unit–‘‘TU’’) each
covering ,500,000 population. A sample size of 922 cases and
922 controls was determined to be sufficient to achieve 80% power
(with a design effect of 2 used to account for single-level cluster
sampling), with an odds-ratio .2 for the hypothesized risk factor
of missing 5 doses prior to default, estimated to occur among 5%
of non-defaulter controls. Given that on average 11 re-treatment
patients defaulted per TU per year in 2006, we estimated that
90 TUs would be required to achieve the sample size. All
2,401 TUs were listed; 564 TUs (23.4%) were excluded due to
security or operational reasons. From the remaining 1,837 TUs,
90 (4.9%) were randomly selected which were distributed in 73
districts across 15 of the 35 States/Union Territories.
Definitions and Patient Selection
We defined ‘cases’ as patients registered in 2006 as re-treatment
case (treatment category II) with a recorded treatment outcome of
default from the TB register. RNTCP defines default as a patient
who has not taken anti-TB drugs for more than 2 months
consecutively any time after starting treatment [3]. From the
selected clusters, all patients who met the case definition were
enrolled. Controls were patients registered as a re-treatment case
who did not default or die during treatment, and were also selected
from the TB register. Patients who died were excluded because of
the absence of complete adherence information. For every case of
default identified, the next consecutively registered re-treatment
patient who did not die or default was selected as a control. The
type of re-treatment TB (relapse, failure, treatment after default or
re-treatment others] as recorded by the providers at the time of
starting treatment on the TB treatment card and TB registers as
per RNTCP guidelines was used to classify patients [3].
Data Source, Collection and Analysis
The data sources used were TB treatment cards and TB
registers. Retrospective data collection was limited to information
available on routine records, including basic clinical and
demographic information, DOT provider type, history of previous
treatment, treatment adherence, adverse reactions, and retrieval
actions. Treatment adherence was assessed from routine recording
of missed doses on treatment cards. Data was abstracted from
RNTCP TB registers and TB treatment cards by programme staff
into Microsoft Excel, and then analyzed with SPSS 11.0 (SPSS
Inc, Chicago, USA) and Epi-Data 2.2. Differences in proportions
between defaulters and non-defaulters were compared using the
chi-square test (or Fisher’s exact test if ,10 observations were
there in any cell). In multivariate logistic regression, we pre-
selected variables for inclusion in the model based on prior
information from studies from other settings on risk factors for
default from new patients, with consideration for information
available on routine records [5,6,7,12,13,14,15,16,17,18]. Infor-
mation on adverse events was excluded from the multivariate
model due to concerns for reporting bias. Information on missed
doses was excluded from the multivariate model as that would not
be available at the beginning of treatment, hence would be of no
value as a predictive factor. Variables were assessed for co-linearity
(none was observed), and model fit assessed using the maximum
likelihood ratio.
Ethical Issues
This retrospective analysis was conducted after review and
approval by the Central TB Division, Directorate General of
Health Services, Ministry of Health and Family Welfare,
Government of India. The activity was determined to be
programme evaluation of the implementation of national guide-
lines. Electronic databases created for this analysis were stripped of
personal health identifiers and maintained securely.
Results
Data Collection
Out of 90 randomly selected TUs for this study, we received
data from 81 (90%), encompassing 2,490 patients (figure 1).
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r e a s o n ss u c ha sl o s so ft r e a t m e nt cards, TB registers or due to
non-availability of staff for data collection. 160 (6.4%) patients
were excluded from the analysis due to incomplete patient
information (78 patients) or non-availability of treatment cards
(82 patients). Of the 2,330 patients included in the final analysis,
1,141 patients were cases and 1,189 patients were controls
(including 773 cured, 352 treatment completed and 64 failure
cases).
Characteristics of Patients Who Defaulted
Of the 1,141 patients who defaulted from treatment, 907 (80%)
were males (table 1). The median age was 38 years (range 7–89
years), and 79.4% were sputum smear-positive. Relatively few
Figure 1. Selection of sampling units and enrollment of cases and controls. Abbreviations: TU=tuberculosis unit (basic programme
management unit, used as cluster sampling units), TAD=registration type ‘‘treatment after default’’.
doi:10.1371/journal.pone.0008873.g001
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comparison to 429 (38%) classified as re-treatment after default.
Nearly one-third (358, 31%) had previous treatment from a source
other than RNTCP. Health facilities served as DOT providers for
829 (73%), with the rest served mainly by private practitioners or
community DOT providers.
The median duration of treatment prior to default was 81 days
(inter-quartile range 44–117 days). Of 1,141 defaulters, 720 (63%)
defaulted within 90 days of treatment, prior to completion of 36
doses in IP (figure 2); another 281 (25%) patients defaulted after
completion of IP but before starting CP, and 140 (12%) patients
defaulted during CP.
Retrieval Actions by the Programme after Treatment
Interruptions (Table 2)
Out of 1,141 defaulters, at least 1 retrieval action was
documented in 726 (64%) patients. Relative to the last dose taken,
the 1
st retrieval action was taken within 1 week in only 328 (45%)
of defaulters; an additional 87 (12%) patients had retrieval actions
during the second week. Out of 726 patients who had any
Table 1. Demographic and clinical characteristics of re-treatment TB patients, defaulters (cases, N=1,141) and non-defaulters








Sex Male 907 (79.5%) 853 (71.7%) 1.56 (1.28–1.89) ,0.01
Female 234 (20.5%) 336 (28.3%) Referent
Age group ,15 years 7 (0.6%) 17 (1.4%) 0.44 (0.17–1.07) 0.05
15–24 years 131 (11.5%) 166 (14.0%) 0.85 (0.63–1.14) 0.26
25–34 years 267 (23.4%) 288 (24.2%) Referent
35–44 years 321 (28.1%) 291 (24.5%) 1.19 (0.94–1.51) 0.13
45–54 years 219 (19.2%) 242 (20.4%) 0.98 (0.76–1.26) 0.84
55–64 years 150 (13.1%) 116 (9.8%) 1.39 (1.03–1.89) 0.26
.65 years 46 (4.0%) 69 (5.8%) 0.72 (0.47–1.10) 0.11
Classification Pulmonary, Smear positive 906(79.4%) 914(76.8%) Referent
Pulmonary, Smear negative 201(17.6%) 221(18.6%) 0.92 (0.74–1.14) 0.42
Pulmonary, Smear unknown 9(0.7%) 14(1.2%) 0.65 (0.26–1.6) 0.31
Extra-pulmonary 25 (2.2%) 40 (3.4%) 0.63 (0.37–1.08) 0.07
Type of TB Relapse 376 (33.0%) 450 (37.8%) Referent
Failure 102 (8.9%) 105 (8.8%) 1.16 (0.85–1.60) 0.33
Treatment after default 429 (37.6%) 364 (30.6%) 1.41 (1.15–1.72) ,0.01
Others 234 (20.5%) 270 (22.7%) 1.04 (0.83–1.30) 0.74
Source of previous Treatment RNTCP 451 (39.5%) 533 (44.8%) Referent
Non-RNTCP 358 (31.4%) 323 (27.2%) 1.31 (1.07–1.60) ,0.01
Data missing 332 (29.1%) 333 (28.0%) 1.18 (0.96–1.44) 0.10
Nature of DOT provider Public health facility 829 (72.7%) 786 (66.1%) Referent
Community provider 155 (13.6%) 159 (13.4%) 0.92 (0.72–1.19) 0.52
Medical college 29 (2.5%) 62 (5.2%) 0.44 (0.28–0.71) ,0.01
Private provider 90 (7.9%) 130 (10.9%) 0.66 (0.49–0.88) ,0.01
Non-governmental organization 34 (3.0%) 49 (4.1%) 0.66 (0.41–1.05) 0.06
Data missing 4 (.4%) 3 (.3%) 1.26 (0.24–7.11) 0.75
Missed doses during intensive
phase of treatment*
1 or more 453 (39.7%) 337 (28.3%) 1.66 (1.39–1.99) ,0.01
2 or more 379 (33.2%) 270 (22.7%) 1.69 (1.40–2.04) ,0.01
3 or more 322 (28.2%) 224 (18.8%) 1.68 (1.37–2.05) ,0.01
4 or more 281 (24.6%) 178 (14.9%) 1.86 (1.50–2.30) ,0.01
5 or more 249 (21.8%) 150 (12.6%) 1.93 (1.54–2.43) ,0.01
6 or more 216 (18.9% 130 (10.9%) 1.90 (1.49–2.42) ,0.01
10 or more 126 (11%) 72 (6%) 1.93 (1.41–2.63) ,0.01
Adverse reaction Documented 119 (10.4%) 5 (0.4%) 27.6 (10.8–76.7) ,0.01
Not documented 1022 (89.6%) 1184 (99.6%) Referent
*Prior to the last dose documented. Sub-categories are mutually exclusive. Referent group for each comparison are those cases and controls with fewer missed doses
than the number evaluated.
doi:10.1371/journal.pone.0008873.t001
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programme staff (senior treatment supervisor or tuberculosis
health visitor], and 154 (21%) were done by staff from the general
health system. In only 11 (2%) instances was any retrieval action
by medical officers (physicians) documented.
Risk Factors for Default
On bivariate analysis (table 1), retreatment patients who
defaulted were more likely to be male than female (odds ratio
[OR] 1.56, 95% confidence interval [CI] 1.28–1.89). Patients who
defaulted were also more likely to have been initially classified as
‘‘treatment after default’’ registration type (OR 1.41, 95% CI
1.15–1.72) or have received previous treatment from a non-
RNTCP provider (OR 1.31, 95% CI 1.07–1.60). Patients who
defaulted had 28 times the odds (95% CI 10.8–76.7) of having
adverse events to anti-TB drugs recorded than patients who did
not default.
Treatment interruptions were more common among defaulters.
Nearly 40% of patients who defaulted and .28% of the non-
defaulters had at least 1 interruption of treatment during IP.
Defaulters were more likely to have missed doses, than patients
who did not default, regardless of the cut-off chosen for number of
missed doses. Five or more missed doses (non-consecutive) or any 3
consecutive missed doses identified defaulters with 79% sensitivity,
and 23% specificity.
Multivariate logistic regression (table 3) showed that indepen-
dent risk factors for default included male sex (adjusted odds ratio
[AOR] 1.42, 95% CI 1.17–1.73), prior default (AOR 1.22, 95%
CI 1.11–1.60), having previous treatment outside RNTCP (AOR
1.28, 95% CI 1.04–1.58), and public health facility based DOT
(AOR 1.33, 95% CI 1.11–1.60). Very elderly patients .65 years
were slightly less likely to default than our reference age category,
(35–44 years).
Reasons for Default Documented
Although the practice was non-systematic, reason for default
during the present retreatment regimen was recorded on the TB
treatment cards of 735 patients (64.4%). Amongst these 735
patients, the most commonly cited reasons were migration 246
(21.6%), refusal 177 (15.5%), treatment from private sector 101
(8.9%), side effects 110 (9.6%), substance abuse 24 (2.1%), and
others (social, HIV, pregnancy) 77 (6.7%).
Discussion
More re-treatment TB patients are notified in India than any
other country in the world, and default among this group is a
serious public health problem [19,20]. This study is the first effort
to describe the characteristics and risk factors for default among
re-treatment TB patients in India, and the efforts made by
RNTCP to retrieve treatment interrupters. In this study, most
defaults were seen to occur early, with 88% occurring before
starting the CP of anti-TB treatment. The transition between IP
and CP appeared to be a particularly vulnerable time for default,
with 25% of all defaults occurring in this time period. These
findings differ from other settings, which have shown the tendency
of default at the later stages of treatment [21].
Independent risk factors for default included male sex, registration
as treatment after default, a history of previous anti-TB treatment
outside of RNTCP, and DOT at a public health facility. The
association of default and male sex has been previously reported for
new patients, and it is unsurprising that previous default is associated
with default during re-treatment [7,22]. The association between
DOT provision at a public health facility and default has not been
reported previously from India. This suggests that limited hours of
operation and accessibility—a reality of many health facilities in
India—may play a role in non-adherence. RNTCP policies very
clearly promote community-based treatment supervision by a DOT
provider who is acceptable and accessible to the patient [3]. Although
re-treatment patients are treated with streptomycin injections for the
first 2 months, local private physicians or registered medical
providers—who can legally provide injections—could be better
utilized as community-based DOT providers.
While missing doses during IP treatment was modestly
associated with default, we found that in practice this would
perform poorly as a signal for potential default. For example,
nearly 40% of patients who defaulted missed at least one dose
Figure 2. Duration of treatment (in days) completed among re-
treatment TB patients who ultimately defaulted from treat-
ment, India 2006 (N=1,141).
doi:10.1371/journal.pone.0008873.g002
Table 2. Documented retrieval actions after treatment
interruptions among retreatment TB patients who ultimately
defaulted from treatment, India 2006 (N=1,141).
Characteristic N (%)
Number of retrieval actions
No retrieval action documented 415 (36%)
At least 1 726 (64%)
At least 2 460 (40%)
At least 3 276 (24%)
At least 4 144 (13%)
Timing of first retrieval action relative to last documented dose (N=726)
0–7 days 328 (45%)
8–14 days 87 (12%)
15–21 days 43 (6%)
22–28 days 24 (3%)
.28 days 214 (30%)
Date of retrieval action not mentioned 30 (4%)
Health staff conducting retrieval action (N=726)
Staff conducting retrieval action not documented 69 (10%)
TB programme staff 492 (67%)
General health system staff (other than medical officer) 154 (21%)
Medical officer 11 (2%)
doi:10.1371/journal.pone.0008873.t002
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60% of patients who ultimately defaulted had no missed doses in IP
documented prior to their default. Hence the usefulness of missing
doses in any number or combination as a warning signal for
potential default is limited.
The independent risk factors we identified were only weakly
associated with default. These findings suggest that profiling
registration data to identify and target re-treatment patients at risk
for default is not likely to be widely successful. A similar
observation on the limited usefulness of patient profiling was
made from a case-control study in Hong Kong [17]. Given the
high rate of default, efforts to promote treatment adherence should
be broadly applied to all re-treatment patients.
This is the first report of RNTCP retrieval efforts for patients
who interrupted treatment and ultimately defaulted. Efforts to
retrieve treatment interrupters were however found to be weak
and far below programme guidelines. Zero retrieval actions were
documented in 415 (36%) of the 1,141 defaulters. In those with
documented retrieval action in more than half the patients it was
delayed by more than 1 week. Contrary to RNTCP guidelines,
staff of the general health system minimally participated in default
retrieval efforts. For example, although programme guidelines are
very clear that default retrieval is chiefly the responsibility of the
treating medical officer, ,2% of the documented retrieval actions
were undertaken by medical officers. Instead, 68% of the
documented retrieval actions were undertaken by the contractual
TB programme staffs, who are few in number and cover large
geographical areas. Actions and documentation of retrieval after
interruption urgently require strengthening.
Limitations
By their nature, retrospective analysis based using routine
records are subject to different types of information bias. The
retrospective nature and the use of existing programme records
limited our ability to assess the association of other risk factors
which have been previously linked to default among new patients.
For example, alcoholism and drug abuse have been previously
associated with default in new patients [6,18]. In this study,
however, amongst those patients with a reason for default
documented on programme records, substance abuse (including
alcohol) was very uncommonly cited. Other risk factors for default
in mainly new patients have been described in other settings, such
as health knowledge, distance to treatment centre, and patients’
economic status; these could not however be assessed in this study
[16,17,23]. Similarly, we lacked information on events such as
prior referral for treatment and migration - both plausible risk
factors for default.
Treatment outcomes were not independently validated; if
patients who had defaulted were misclassified as completed
treatment in programme records, our ability to detect risk factors
would have been diluted. The RNTCP, however, maintains a
system of ongoing internal programme evaluation and review
including periodic validations of recorded data and patient
treatment outcomes. Thus widespread misclassification of treat-
ment outcome is unlikely to have occurred. Our finding of a strong
association between adverse events and default was likely
influenced by reporting bias; hence, this finding should be
interpreted with caution. The association between adverse events
and default may be overestimated, and we were sufficiently
concerned to exclude adverse events a priori from our multivariate
model.
Translating Findings into Policy and Practice
RNTCP has begun strengthening several areas to prevent and
reduce default in re-treatment patients. RNTCP has enhanced it’s
monitoring of re-treatment outcomes in programme reviews and
Table 3. Multivariate analysis of risk factors for default among re-treatment tuberculosis patients–India, 2006 (Default cases=807,
Control cases=853).
Characteristic Sub-Category Adjusted Odds Ratio 95% Confidence Limits P- value
Sex Male 1.42 1.16–1.73 ,0.01
Female Referent
Age ,15 years 0.49 0.19–1.22 0.12
15–24 years 0.79 0.59–1.04 0.10
25–34 years 0.87 0.68–1.09 0.23
45–54 years 0.81 0.63–1.03 0.09
55–64 years 1.12 0.84–1.51 0.43
:.65 years 0.60 0.40–0.91 0.02
35–44 years Referent
Type of TB Failure 1.14 0.84–1.56 0.39
Treatment after default 1.31 1.07–1.61 ,0.01
Other 0.98 0.77–1.24 0.86
Relapse Referent
DOT Provider Public health facility 1.33 1.11–1.60 ,0.01
Other facility* Referent
Source of prior treatment Non-RNTCP 1.28 1.04–1.57 ,0.01
Data not reported 1.14 0.92–1.40 0.21
RNTCP Referent
*includes medical colleges, private practitioners, community treatment providers, and non-governmental organizations.
doi:10.1371/journal.pone.0008873.t003
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education on the need for completing the full course of anti-TB
treatment, emphasis during trainings on pre-treatment counseling
has been coupled with the development of a standard patient
information booklet, distributed in all languages with every box of
RNTCP anti-TB drugs. To promote community-based treatment,
the Central Unit has begun monitoring the proportion of patients
treated by community-based DOT providers. Furthermore, local
programme officers are being asked to provide greater emphasis
on general health staff involvement with prompt retrieval actions
by local providers and monitor treatment provision for patients
who migrate during treatment.
Conclusions
Defaulting from treatment is common among the large number
of re-treatment patients in India. Default usually occurs early
during treatment, particularly in the transition period from the IP
to CP of treatment, and was weakly associated with male sex, prior
default, prior treatment from a private provider, and DOT from a
public health facility. Efforts to retrieve treatment interrupters fell
far short of programme guidelines. Efforts to improve pre-
treatment counseling, increase the proportion of patients treated
by community-based treatment providers, and strengthen retrieval
of treatment interrupters should yield immediate impact on default
rates.
This study, however, represents a starting point from where the
RNTCP can begin to comprehensively seek to understand and
reduce treatment default. Future prospective studies should seek to
investigate the roles of other important risk factors that we could
not assess in this retrospective analysis. Qualitative research to
understand the challenges faced by patients and providers would
further aid in pragmatic programmatic decision making.
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